Literature DB >> 13711121

Administration of 5-iododeoxyuridine-I-131 in the mouse and rat.

E G HAMPTON, M L EIDINOFF.   

Abstract

Entities:  

Keywords:  NEOPLASMS/experimental; NUCLEOSIDES AND NUCLEOTIDES/pharmacology; PYRIMIDINES/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13711121

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  Auger electron emitters: insights gained from in vitro experiments.

Authors:  G Makrigiorgos; S J Adelstein; A I Kassis
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

2.  Brain parenchymal metabolism of 5-iodo-2'-deoxyuridine and 5'-ester prodrugs.

Authors:  M K Ghosh; A K Mitra
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

3.  Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs.

Authors:  J Samuel; M J Gill; T Iwashina; D R Tovell; D L Tyrrell; E E Knaus; L I Wiebe
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.

Authors:  K D Bagshawe; J Boden; G M Boxer; D W Britton; A Green; T Partridge; B Pedley; S Sharma; P Southall
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

5.  Highly Effective Auger-Electron Therapy in an Orthotopic Glioblastoma Xenograft Model using Convection-Enhanced Delivery.

Authors:  Helge Thisgaard; Bo Halle; Charlotte Aaberg-Jessen; Birgitte Brinkmann Olsen; Anne Sofie Nautrup Therkelsen; Johan Hygum Dam; Niels Langkjær; Sune Munthe; Kjell Någren; Poul Flemming Høilund-Carlsen; Bjarne Winther Kristensen
Journal:  Theranostics       Date:  2016-09-29       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.